RetiSpec Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 31

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 22

RetiSpec General Information

Description

Developer of an Artificial Intelligence-driven retinal imaging technology intended for early Alzheimer's detection. The company's technology utilizes a simple eye exam to identify neurodegenerative disease markers, enabling healthcare providers to offer accessible, affordable, and scalable early diagnosis.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 170 Bedford Road
  • Unit 200
  • Toronto, Ontario M5R 2K9
  • Canada
Primary Industry
Decision/Risk Analysis
Other Industries
Diagnostic Equipment
Corporate Office
  • 170 Bedford Road
  • Unit 200
  • Toronto, Ontario M5R 2K9
  • Canada

RetiSpec Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RetiSpec Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Accelerator/Incubator 04-Sep-2024 Completed Generating Revenue
11. Later Stage VC (Series A) 26-Jul-2024 Completed Generating Revenue
10. Accelerator/Incubator 01-Dec-2023 Completed Generating Revenue
9. Accelerator/Incubator 13-Apr-2023 Completed Generating Revenue
8. Accelerator/Incubator 01-Nov-2020 Completed Generating Revenue
7. Seed Round 01-Feb-2020 Completed Generating Revenue
6. Grant 08-Oct-2019 Completed Generating Revenue
5. Seed Round 23-Oct-2018 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2018 Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
To view RetiSpec’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

RetiSpec Patents

RetiSpec Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260090709-A1 Evaluating spectropolarimetric data packages of an eye for markers of disease Pending 23-Nov-2022
WO-2024115962-A2 Evaluating spectropolarimetric data packages of an eye for markers of disease Inactive 23-Nov-2022
WO-2024115962-A3 Evaluating spectropolarimetric data packages of an eye for markers of disease Inactive 23-Nov-2022
WO-2024115962-A9 Evaluating spectropolarimetric data packages of an eye for markers of disease Inactive 23-Nov-2022
EP-4599220-A1 Systems and methods for calibrating spectral devices Pending 07-Oct-2022 A61B3/0016
To view RetiSpec’s complete patent history, request access »

RetiSpec Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RetiSpec Investors (22)

Investor Name Investor Type Holding Investor Since Participating Rounds
C100 (Commercial Services) Accelerator/Incubator Minority
CRP Group (Clinics/Outpatient Services) Corporation Minority
Gentex Corporation Minority
Lilly USA Corporation Minority
Micasa Investments Venture Capital Minority
You’re viewing 5 of 22 investors. Get the full list »

RetiSpec FAQs

  • When was RetiSpec founded?

    RetiSpec was founded in 2016.

  • Where is RetiSpec headquartered?

    RetiSpec is headquartered in Toronto, Canada.

  • What is the size of RetiSpec?

    RetiSpec has 31 total employees.

  • What industry is RetiSpec in?

    RetiSpec’s primary industry is Decision/Risk Analysis.

  • Is RetiSpec a private or public company?

    RetiSpec is a Private company.

  • What is RetiSpec’s current revenue?

    The current revenue for RetiSpec is .

  • How much funding has RetiSpec raised over time?

    RetiSpec has raised $18.2M.

  • Who are RetiSpec’s investors?

    C100 (Commercial Services), CRP Group (Clinics/Outpatient Services), Gentex, Lilly USA, and Micasa Investments are 5 of 22 investors who have invested in RetiSpec.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process